TerrAscend (TSNDF) Tax Provisions (2021 - 2026)
TerrAscend (TSNDF) posted quarterly Tax Provisions of $10.2 million for Q1 2026, down 2.45% year-over-year from $10.5 million in Q1 2025, and up 712.67% quarter-over-quarter from -$1.7 million in Q4 2025.
TerrAscend (TSNDF) Tax Provisions (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has reported Tax Provisions for 6 consecutive years, with $10.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Tax Provisions fell 2.45% year-over-year to $10.2 million; the TTM figure through Mar 2026 stood at $29.2 million (up 4084.86% YoY), while the FY2025 annual figure was $29.5 million, up 921.47% from the prior year.
- Tax Provisions climbed to $10.2 million in Q1 2026 per TSNDF's latest filing, from -$1.7 million in the prior quarter.
- Across five years, Tax Provisions topped out at $18.5 million in Q4 2022 and bottomed at -$34.0 million in Q3 2022.
- Historically, Tax Provisions has averaged $3.8 million across 5 years, with a median of $9.6 million in 2025.
- Annual changes were most pronounced in 2023 — Tax Provisions jumped 238.34% — and 2024, when it slumped 3515.13%.
- TerrAscend's Tax Provisions stood at $18.5 million in 2022, then slumped by 94.69% to $985000.0 in 2023, then plunged by 3515.13% to -$33.6 million in 2024, then surged by 95.03% to -$1.7 million in 2025, then soared by 712.67% to $10.2 million in 2026.
- Business Quant data shows TSNDF's Tax Provisions at $10.2 million in Q1 2026, -$1.7 million in Q4 2025, and $11.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TerrAscend | 182.53 Mn | 140.41 Mn | 36.25 Mn | 11.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.59 Mn |
| Mar 31, 2026 | 10.25 Mn |
| Dec 31, 2025 | -1.67 Mn |
| Sep 30, 2025 | 11.03 Mn |
| Jun 30, 2025 | 9.60 Mn |
| Mar 31, 2025 | 10.51 Mn |
| Dec 31, 2024 | -33.64 Mn |
| Sep 30, 2024 | 13.27 Mn |
| Jun 30, 2024 | 9.13 Mn |
| Mar 31, 2024 | 9.67 Mn |
| Dec 31, 2023 | 985,000.00 |
| Sep 30, 2023 | 13.54 Mn |
| Jun 30, 2023 | 6.45 Mn |
| Mar 31, 2023 | 12.66 Mn |
| Dec 31, 2022 | 18.54 Mn |
| Sep 30, 2022 | -34.03 Mn |
| Jun 30, 2022 | 4.69 Mn |
| Mar 31, 2022 | 3.74 Mn |
| Dec 31, 2021 | 8.75 Mn |
| Sep 30, 2021 | 5.00 Mn |